Inflammatory bowel disease induced by bimekizumab
Inflammatory bowel disease (IBD) is a chronic condition of the gastrointestinal tract, with a complex aetiopathogenesis in which genetic, immunological, and environmental factors are being discussed. The development of knowledge about molecular processes and the aetiology of diseases are made possib...
Saved in:
Main Authors: | Dominika Wietrzykowska-Grishanovich, Maciej Pleskacz, Radosław Kempiński |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2022-05-01
|
Series: | Gastroenterology Review |
Online Access: | https://www.termedia.pl/Inflammatory-bowel-disease-induced-by-bimekizumab,41,47056,1,1.html |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Influence of Nutrients on Inflammatory Bowel Diseases
by: Sara Jarmakiewicz-Czaja, et al.
Published: (2020-01-01) -
Biological markers of disease activity in inflammatory bowel diseases
by: Edyta Szymanska, et al.
Published: (2023-07-01) -
Successful treatment of severe acrodermatitis continua of hallopeau with Bimekizumab: A case report
by: Lily Xu, et al.
Published: (2025-01-01) -
Biosimilar biological drugs in the treatment of inflammatory bowel diseases
by: Magdalena Kaniewska, et al.
Published: (2019-12-01) -
Halitosis as a symptom of gastroenterological diseases
by: Elżbieta Poniewierka, et al.
Published: (2022-03-01)